ALK-ABELLÓ A/S: Financial statements 2024
CVR: 63717916
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
ALK-ABELLÓ A/S (CVR 63717916) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 5,537,000,000 and a net result of DKK 815,000,000 compared with DKK 486,000,000 the year before. That is an increase of 14.8% compared with the year before. The profit margin was 14.7%. Equity in the 2024 report amounted to DKK 5,373,000,000. The solvency ratio was 65.2%. The company had 2,789 employees in the financial year.
- Revenue
- DKK 5,537,000,000
- Gross Profit
- DKK 3,552,000,000
- Profit/Loss
- DKK 815,000,000
- Equity
- DKK 5,373,000,000
- Total Assets
- DKK 8,246,000,000
- Employees
- 2,789
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 5.5B | 3.6B | 815M | 5.4B | 2789 |
| 2023 | 4.8B | 3B | 486M | 4.4B | 2752 |
| 2022 | 4.5B | 2.8B | 335M | 4B | - |
| 2021 | 3.9B | 2.4B | 219M | 3.5B | 2492 |
| 2020 | 3.5B | 2B | 25M | 3.2B | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2024 to September 30, 2024.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2024 to June 30, 2024.
ALK-ABELLÓ A/S has published its interim report for the period January 1, 2024 to March 31, 2024.
ALK-ABELLÓ A/S has published its annual report for 2023. Revenue came to DKK 4,824,000,000, and the net result was DKK 486,000,000.
As of March 14, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ALK-ABELLÓ A/S.
About ALK-ABELLÓ A/S
ALK-ABELLÓ A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1961. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ALK A/S and ALLERGOLOGISK LABORATORIUM A/S. The management consists of Peter Halling and Claus Steensen Sølje. The board consists of Anders Hedegaard (chair), Lene Skole-Sørensen, Alan Main and Bertil Erik Lindmark. The company is owned by LUNDBECKFOND INVEST A/S. The company has 1,017 employees (2026). In 2025, the company reported revenue of DKK 6,312,000,000 and a net result of DKK 1,197,000,000 compared with DKK 815,000,000 the year before. Equity in the 2025 report amounted to DKK 6,445,000,000.